Martin Kassir

Dr. Martin Kassir


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
RDRachita Dhurat
Rachita Dhurat
ASAseem Sharma
Aseem Sharma
LRLidia Rudnicka
Lidia Rudnicka
George KroumpouzosGeorge Kroumpouzos
George Kroumpouzos
Martin KassirMartin Kassir
Martin Kassir
Mohamad GoldustMohamad Goldust
Mohamad Goldust

31 December 2019 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
KAKomal Agarwal
Komal Agarwal
IPIndrashis Podder
Indrashis Podder
Martin KassirMartin Kassir
Martin Kassir
AVAleksandra Vojvodic
Aleksandra Vojvodic
Robert A SchwartzRobert A Schwartz
Robert A Schwartz
Mohamad GoldustMohamad Goldust
Mohamad Goldust

1 July 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
LRLidia Rudnicka
Lidia Rudnicka
MGMrinal Gupta
Mrinal Gupta
Martin KassirMartin Kassir
Martin Kassir
MJMohammad Jafferany
Mohammad Jafferany
Torello LottiTorello Lotti
Torello Lotti
Mohamad GoldustMohamad Goldust
Mohamad Goldust
Click on the book chapter title to read more.

1 January 2013 in Journal of Cutaneous and Aesthetic Surgery
Verified
Journal Article
Open access
PDF file
Martin KassirMartin Kassir
Martin Kassir
KSKanika Sahni
Kanika Sahni
Periorbital melanosis (under eye dark circles) is an often idiopathic cosmetically disturbing condition that is poorly responsive to currently available treatment modalities. We present the case of a 48-year-old man (skin phototype V) with significant idiopathic periorbital melanosis and who had good to excellent reduction in periorbital melanosis with the new DermaFrac TM , which combines microneedling with simultaneous infusion of a serum containing active ingredients. The possible mechanisms of benefit are discussed. DermaFrac TM may be an innovative and effective new treatment option for patients with periorbital melanosis.

8 December 2021 in Biology
Verified
Journal Article
Open access
PDF file
P Umar Farooq BabaP Umar Farooq Baba
P Umar Farooq Baba
ZRZubaida Rasool
Zubaida Rasool
IKIshrat Khan
Ishrat Khan
CCClay J Cockerell
Clay J Cockerell
RWRichard Wang
Richard Wang
Mohamad GoldustMohamad Goldust
Mohamad Goldust
Merkel cell carcinoma (MCC) is an infrequent, rapidly growing skin neoplasm that carries a greater probability of regional lymph node involvement, and a grim prognosis in advanced cases. While it is seen predominantly in old age in sun-exposed body parts, the prevalence varies among different races and geographical regions. Merkel cell polyomavirus and UV radiation-induced mutations contribute to its etiopathogenesis. The clinical presentation of MCC lacks pathognomonic features and is rarely considered highly at the time of presentation. Histopathological examination frequently reveals hyperchromatic nuclei with high mitotic activity, but immunohistochemistry is required to confirm the diagnosis. Sentinel lymph node biopsy (SLNB) and imaging are advised for effective staging of the disease. Multimodal management including surgery, radiation therapy, and/or immunotherapy are deployed. Traditional cytotoxic chemotherapies may result in an initial response, but do not result in a significant survival benefit. Checkpoint inhibitors have dramatically improved the prognosis of patients with metastatic MCC, and are recommended first-line in advanced cases. There is a need for well-tolerated agents with good safety profiles in patients who have failed immunotherapies.

23 March 2021 in Cosmetics
Verified
Journal Article
Open access
PDF file
SSSwathi Shivakumar
Swathi Shivakumar
Martin KassirMartin Kassir
Martin Kassir
LRLidia Rudnicka
Lidia Rudnicka
HGHassan Galadari
Hassan Galadari
Stephan GrabbeStephan Grabbe
Stephan Grabbe
Mohamad GoldustMohamad Goldust
Mohamad Goldust
Androgenetic alopecia (AGA) is the most common type of baldness and its incidence has increased over the past few years with an earlier age of onset being widely reported all over the world. Although it is reported more often in men, it affects women as well. With the growing cosmetic concern of patients, emphasis has shifted from the more traditional treatment options such as finasteride and minoxidil to surgical options such as hair transplantation. This review briefly highlights all of the treatment options available for AGA so far. A special focus is on current data available on hair transplantation surgeries and the various methods, merits and demerits and limitations of surgery. The literature research considered published journal articles (scientific reviews) from 1990 to date. Studies were identified by searching electronic databases (MEDLINE and PubMed) and the reference lists of respective articles. Only articles available in English were considered for this review.